Connor, Clark & Lunn Investment Management Ltd. Enovis Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Enovis Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 126,440 shares of ENOV stock, worth $5.56 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
126,440
Previous 158,083
20.02%
Holding current value
$5.56 Million
Previous $7.15 Million
23.82%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.2MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$292 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$239 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$238 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$132 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$131 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.38B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...